Medical News Hubb
Advertisement
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
Medical News Hubb
No Result
View All Result
Home Medicines & Healthy Lifestyle

Ivermectin For COVID-19? Not Effective, Says Large Study

admin by admin
August 21, 2022
in Medicines & Healthy Lifestyle


A large study has finally laid to rest the claims that ivermectin is effective against COVID-19. 

The controversial horse dewormer gained traction in the early days of the pandemic when some experts claimed it could treat the disease caused by SARS-CoV-2. 

The demand for the drug somehow increased as many promoted its use against COVID, especially on social media. A doctor group even recommended ivermectin as one of the “i-recover” protocol of medications for the viral disease in February. 

But a long-awaited study at the University of Minnesota finally gave its verdict on the drug, saying it was not effective at treating COVID-19. 

Published in the New England Journal of Medicine, the researchers behind the study found that the antiparasitic drug did not have the capacity to treat a SARS-CoV-2 infection. 

For the study, the team focused on three common drugs claimed to have shown promise against COVID: ivermectin, the diabetes drug metformin and the antidepressant fluvoxamine. 

According to the researchers, none of the three proved effective at preventing low oxygen levels, ER visits, hospitalizations and even death due to COVID-19. 

“None of the three medications that were evaluated prevented the occurrence of hy- poxemia, an emergency department visit, hospitalization, or death associated with Covid-19,” they wrote. 

A total of 1,431 patients enrolled in the trial of the drugs from Dec. 30, 2020, through Jan. 28, 2022. However, only 1,323 patients moved forward with the primary analysis after screening. 

The patients were randomly assigned to six trial groups with different treatment setups: metformin plus fluvoxamine, metformin plus ivermectin, metformin plus placebo, placebo plus fluvoxamine, placebo plus ivermectin and placebo plus placebo. 

Though ivermectin and fluvoxamine did not present any efficacy against COVID-19, the diabetes drug metformin showed some promise. But the data collected by the researchers was not definitive. 

“We’re just really grateful to be able to share our work broadly and to have been published in a medical journal,” lead researcher Dr. Carolyn Bramante told KSTP-TV. 

The team’s study adds to the growing evidence on ivermectin being ineffective against SARS-CoV-2 infection. Another study published in the same journal in March found that ivermectin did nothing to treat COVID-19 patients. The drug even yielded worse outcomes than the placebo.





Source link

Tags: 19covideffectiveivermectinlargenotsaysstudy
Previous Post

Autoimmune Patients’ COVID Vax Durability Studied In-Depth

Next Post

Behavioral Therapy Tied to Reduced Tic Severity in Youth With Tourette Syndrome

Next Post

Behavioral Therapy Tied to Reduced Tic Severity in Youth With Tourette Syndrome

Recommended

Pfizer’s experimental RSV vaccine protects older adults in study

August 25, 2022

Health Bulletin 6/September/2022

September 6, 2022

Don't miss it

Pharmaceutical

Strange bedfellows lobby for Medicare obesity-drug coverage

January 26, 2023
Medicines & Healthy Lifestyle

FDA Panel Votes on Rezafungin for Treatment of Candidemia, Invasive Candidiasis

January 26, 2023
Medicines & Healthy Lifestyle

This Cancer Drug Can Increase Longevity, Study Finds

January 26, 2023
News

Something in Breast Milk Helps Protect Babies Against Allergies

January 26, 2023
Pharmaceutical

Merck ends late-stage trial for Keytruda in prostate cancer

January 25, 2023
Medicines & Healthy Lifestyle

Are Seed Oils Behind the Majority of Diseases This Century?

January 25, 2023

© 2022 Medical News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

Newsletter Sign Up

No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

© 2022 Medical News Hubb All rights reserved.